Efficacy  	Efficacy  	 NNP	O
of  	of  	 IN	O
595nm  	595nm  	 CD	O
pulsed  	pulsed  	 CD	B-NP
dye  	dye  	 JJ	I-NP
laser  	laser  	 NN	I-NP
therapy  	therapy  	 NN	I-NP
for  	for  	 IN	I-NP
Mibelli  	Mibelli  	 NNP	I-NP
angiokeratoma  	angiokeratoma  	 VBD	O
To  	To  	 TO	O
retrospectively  	retrospectively  	 VB	O
study  	study  	 VB	O
the  	the  	 DT	O
clinical  	clinical  	 JJ	B-NP
efficacy  	efficacy  	 NN	I-NP
of  	of  	 IN	O
595nm  	595nm  	 CD	O
pulsed  	pulsed  	 CD	B-NP
dye  	dye  	 JJ	I-NP
laser  	laser  	 NN	I-NP
therapy  	therapy  	 NN	I-NP
for  	for  	 IN	I-NP
Mibelli  	Mibelli  	 NNP	I-NP
angiokeratoma.  	angiokeratoma.  	 CD	I-NP
50  	50  	 CD	O
cases  	cases  	 NNS	O
of  	of  	 IN	O
Mibelli  	Mibelli  	 NNP	B-NP
angiokeratoma 	angiokeratoma 	 NN	I-NP
,  	,  	 ,	O
from  	from  	 IN	O
10  	10  	 CD	O
to  	to  	 TO	O
41  	41  	 CD	O
year-old，were  	year-old，were  	 CD	B-NP
treated  	treated  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
595nm  	595nm  	 FW	O
pulsed  	pulsed  	 FW	O
dye  	dye  	 FW	O
laser 	laser 	 FW	O
.  	.  	 .	O
The  	The  	 DT	O
parameters  	parameters  	 NN	O
were  	were  	 VBD	O
as  	as  	 RB	O
follows 	follows 	 VBZ	O
:  	:  	 :	O
a  	a  	 DT	O
wavelength  	wavelength  	 NN	O
of  	of  	 IN	O
595  	595  	 CD	O
nm 	nm 	 NN	B-NP
,  	,  	 ,	O
pulse  	pulse  	 JJ	B-NP
duration  	duration  	 NN	I-NP
of  	of  	 IN	O
10ms 	10ms 	 NNP	O
,  	,  	 ,	O
spot  	spot  	 NN	O
size  	size  	 NN	O
of  	of  	 IN	O
7  	7  	 CD	O
mm  	mm  	 NNS	O
and  	and  	 CC	O
energy  	energy  	 NN	B-NP
fluency  	fluency  	 NN	I-NP
of  	of  	 IN	O
12.0-13.5  	12.0-13.5  	 NNP	O
J 	J 	 NNP	B-NP
/ 	/ 	 FW	I-NP
cm 	cm 	 FW	I-NP
( 	( 	 -LRB-	I-NP
2 	2 	 LS	I-NP
) 	) 	 -RRB-	I-NP
.  	.  	 .	O
The  	The  	 DT	O
treatments  	treatments  	 NNS	O
were  	were  	 VBD	O
repeated  	repeated  	 VBN	O
at  	at  	 IN	O
intervals  	intervals  	 NNS	O
of  	of  	 IN	O
4-6  	4-6  	 CD	O
weeks  	weeks  	 NNS	O
until  	until  	 IN	O
the  	the  	 DT	O
lesion  	lesion  	 NN	B-NP
was  	was  	 VBD	O
cleared 	cleared 	 VBN	O
,  	,  	 ,	O
or  	or  	 CC	O
the  	the  	 DT	O
parents  	parents  	 NNS	O
discontinued  	discontinued  	 VBN	O
the  	the  	 DT	O
treatment 	treatment 	 NN	O
.  	.  	 .	O
Detailed  	Detailed  	 JJ	B-NP
demographics  	demographics  	 NNS	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
assessment  	assessment  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
degree  	degree  	 NN	O
of  	of  	 IN	O
lesion  	lesion  	 JJ	B-NP
clearance  	clearance  	 NN	I-NP
were  	were  	 VBD	O
statistically  	statistically  	 RB	O
analyzed  	analyzed  	 VBN	O
through  	through  	 IN	O
SASS18.0 	SASS18.0 	 CD	B-NP
.  	.  	 .	O
All  	All  	 PDT	O
the  	the  	 DT	O
50  	50  	 CD	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
treated  	treated  	 VBN	O
1-4  	1-4  	 CD	O
times 	times 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
total  	total  	 JJ	B-NP
rate  	rate  	 NN	I-NP
of  	of  	 IN	O
significant  	significant  	 JJ	O
improvement  	improvement  	 NN	O
was  	was  	 VBD	O
80 	80 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
rate  	rate  	 NN	O
of  	of  	 IN	O
full  	full  	 JJ	O
recovery  	recovery  	 NN	O
was  	was  	 VBD	O
30 	30 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
We  	We  	 PRP	O
failed  	failed  	 VBD	O
to  	to  	 TO	O
find  	find  	 VB	O
statistical  	statistical  	 JJ	B-NP
significance  	significance  	 NN	I-NP
between  	between  	 IN	O
genders 	genders 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
the  	the  	 DT	O
size  	size  	 NN	O
and  	and  	 CC	O
color  	color  	 NN	O
of  	of  	 IN	O
lesions 	lesions 	 NNS	O
,  	,  	 ,	O
which  	which  	 WDT	O
might  	might  	 MD	O
be  	be  	 VB	O
due  	due  	 JJ	O
to  	to  	 TO	O
limited  	limited  	 JJ	O
sample  	sample  	 NN	O
size 	size 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
most  	most  	 RBS	O
common  	common  	 JJ	O
adverse  	adverse  	 JJ	O
effects  	effects  	 NNS	O
after  	after  	 IN	O
treatment  	treatment  	 NN	O
were  	were  	 VBD	O
purpura  	purpura  	 JJ	B-NP
and  	and  	 CC	O
edema 	edema 	 NN	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
usually  	usually  	 RB	O
lasted  	lasted  	 VBN	O
for  	for  	 IN	O
12  	12  	 CD	O
h  	h  	 NN	O
to  	to  	 TO	O
several  	several  	 JJ	O
days 	days 	 NNS	O
.  	.  	 .	O
Temporary  	Temporary  	 JJ	B-NP
pigment  	pigment  	 NN	I-NP
alterations  	alterations  	 NNS	I-NP
were  	were  	 VBD	O
not  	not  	 RB	O
common 	common 	 JJ	O
.  	.  	 .	O
Other  	Other  	 JJ	O
side  	side  	 NN	O
effects  	effects  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
scar  	scar  	 NN	O
or  	or  	 CC	O
skin  	skin  	 NN	O
texture  	texture  	 NN	O
change  	change  	 NN	O
were  	were  	 VBD	O
not  	not  	 RB	O
observed 	observed 	 VBD	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
experience  	experience  	 NN	O
confirmed  	confirmed  	 VBD	O
the  	the  	 DT	O
clinical  	clinical  	 JJ	B-NP
efficacy  	efficacy  	 NN	I-NP
and  	and  	 CC	O
safety  	safety  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
595  	595  	 CD	O
nm  	nm  	 NNS	B-NP
pulse  	pulse  	 VBP	O
dye  	dye  	 JJ	O
laser  	laser  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
Mibelli  	Mibelli  	 NNP	B-NP
angiokeratoma 	angiokeratoma 	 NN	I-NP
.  	.  	 .	O
